COLL vs SIGA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
COLL Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Collegium Pharmaceutical, Inc. Common Stock (COLL) driven by superior Valuation, Growth & Margin, Momentum & Technical while SIGA counters with relative strength in Options & Structure. Fundamentally, COLL trades at 3.5x Forward P/E with 22.9% operating margin (+3.3% YoY revenue) versus SIGA at 2.3x Forward P/E and -14.2% operating margin (-49.7% YoY). In options structure, COLL sits in BREAKDOWN (20th %ile IV; Dealer Gamma Walls on Pro) against SIGA sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | COLL Revenue | SIGA Revenue | COLL Op. Margin | SIGA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $280M | $480M | -7.4% | 74.4% | SIGA |
| FY2019 | $300M | $30M | -8.0% | -8.7% | COLL |
| FY2020 | $310M | $120M | 18.1% | 67.6% | SIGA |
| FY2021 | $280M | $130M | 6.4% | 66.7% | SIGA |
| FY2022 | $460M | $110M | 7.2% | 38.5% | SIGA |
| FY2023 | $570M | $140M | 29.5% | 59.8% | SIGA |
| FY2024 | $630M | $140M | 26.9% | 50.4% | SIGA |
| FY2025 | $780M | $90M | 23.0% | 25.1% | SIGA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | COLL | SIGA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $783.4M | $188.3M | Larger Scale | COLL |
| Trailing P/E Ratio Valuation | 23.1x | N/M | Lower Multiple | COLL |
| Forward P/E Ratio Valuation | 3.5x | 2.3x | Lower Multiple | SIGA |
| Revenue Growth (YoY) Growth | +3.3% | -49.7% | Higher Growth | COLL |
| Operating Margin (TTM) Profitability | 22.9% | -14.2% | Higher Margin | COLL |
| Net Profit Margin Profitability | 4.7% | 1.3% | Higher Margin | COLL |
| Return on Equity (ROE) Capital Efficiency | 13.4% | 0.4% | Higher ROE | COLL |
| 52-Week Range Position Momentum | 11% ($21โ$51) | 2% ($2โ$7) | Stronger Trend | COLL |
| Beta / 30D Volatility Risk Regime | 0.10ฮฒ ยท 34% Vol | 0.90ฮฒ ยท 74% Vol | Lower Realized Risk | COLL |
| Unified Institutional Score Composite Signal | 31.5 / 100 (SELL) | 46.2 / 100 (HOLD) | Higher Composite | SIGA |